the outcomes of patients with al amyloidosis and end-stage renal disease
Published 1 month ago • 64 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
5:07
daratumumab in the management of al amyloidosis
-
1:55
factors predicting outcomes in patients with al amyloidosis treated with daratumumab
-
1:03
real-world management of patients with al amyloidosis
-
1:19
al amyloidosis: mrd negativity
-
5:17
amyloidosis: the voice of the patient
-
4:33
organ involvement in al amyloidosis
-
4:52
an overview of al amyloidosis
-
0:48
an overview of challenges that remain in the treatment of patients with al amyloidosis
-
0:45
difference between quality of life & patient-reported outcomes
-
0:52
tocilizumab for aa amyloidosis
-
1:10
exploring the next era of treating al amyloidosis: role of birtamimab
-
8:24
hrqol, diagnosis and treatment experiences of patients with al amyloidosis: a survey by mpe
-
2:00
al amyloidosis: hot topics from isa 2020
-
4:14
defining primary refractory disease and its effect on patient outcomes in dlbcl
-
3:19
supportive care in al amyloidosis
-
2:56
early vs. deferred transplantation in al amyloidosis
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
4:04
management of al amyloidosis: measurement modalities, transplantation & car-t
-
5:16
the evolution of al amyloidosis therapy
-
1:45
real-world data in guiding amyloidosis treatment